SCHEMBL5847966

SCHEMBL5847966

CCOC(=O)CC(CC(=O)CCl)c1ccc(F)c(F)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F10 P00742 4/20 0.39
F2 P00734 4/20 0.39
ALDH1A1 P00352 4/20 0.39
MAPT P10636 3/20 0.39
KDM4E B2RXH2 3/20 0.38
HTT P42858 1/20 0.38
PRSS1 P07477 1/20 0.38
MEN1 O00255 1/20 0.37
GAA P10253 1/20 0.37
KMT2A Q03164 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
CES2 O00748 1/20 0.35
CES1 P23141 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
LMNA P02545 1/20 0.35
TSHR P16473 2/20 0.35
HPGD P15428 1/20 0.35
NLRP3 Q96P20 1/20 0.34
TP53 P04637 1/20 0.34
THRB P10828 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5847662 0.88 HTT (0.46) F10F2ALDH1A1KDM4EHTT
SCHEMBL5848181 0.83 F2 (0.45) F10F2ALDH1A1MAPTKDM4E
SCHEMBL5847413 0.83 F10 (0.44) F10F2ALDH1A1MAPTPRSS1
SCHEMBL5847519 0.82 F2 (0.46) F10F2ALDH1A1MAPTKDM4E
SCHEMBL20475388 0.80 KDM4E (0.44) F10F2ALDH1A1MAPTKDM4E
SCHEMBL8771004 0.79 CES2 (0.43) F10F2ALDH1A1MAPTKDM4E
SCHEMBL6218817 0.79 RAB9A (0.47) ALDH1A1MAPTKDM4EHTTMEN1
SCHEMBL5847699 0.79 RAB9A (0.47) ALDH1A1MAPTKDM4EHTTMEN1
SCHEMBL20380272 0.78 FFAR1 (0.44) F10F2ALDH1A1KDM4EHTT
SCHEMBL21562764 0.76 TAS1R3 (0.42) ALDH1A1KDM4EHTTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7115596-B2 Thiazole compounds as integrin receptor antagonists derivatives PHARMACIA CORPORATION (US) 2006-10-03 US disclosed
EP-1572690-A1 THIAZOLE COMPOUNDS AS INTEGRIN RECEPTOR ANTAGONISTS DERIVATIVES Pharmacia Corporation (US) 2005-09-14 EP disclosed
US-20050004189-A1 Thiazole compounds as integrin receptor antagonists derivatives PHARMACIA CORPORATION 2005-01-06 US disclosed
WO-2004058760-A1 THIAZOLE COMPOUNDS AS INTEGRIN RECEPTOR ANTAGONISTS DERIVATIVES PHARMACIA CORPORATION (US) 2004-07-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050004189-A1 Thiazole compounds as integrin receptor antagonists derivatives ITGA5, ITGB5, ITGAL F10 1591/4885F2 2878/4885ALDH1A1 1404/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.